The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/183480
2013 CMO Leadership Awards Winner Profiles DRUG TYPE: Biopharmaceuticals BioReliance Rockville, MD Manufacturing locations: Carlsbad, CA, U.S.A. and Glasgow, Scotland, U.K. www.bioreliance.com (301) 738-1000 Contact: Mike Garrett mike.garrett@bioreliance.com DRUG LIFE CYCLE STAGES: Research & Development — discovery, preclinical, clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development and drug substance production SERVICES OFFERED: Aseptic fill/finish, injectables, liquids, parenterals (small volume), proteins, vaccines, and others. "BioReliance is pleased to once again be recognized in several categories of the CMO Leadership awards. Our entire organization is driven by the desire to supply customers with reliable on-quality and on-time delivery of expert scientific services. These wins serve as internal validation that drug developers and manufacturers feel they can rely on BioReliance, and we will continue to work towards delivering on that vote of confidence." — Archie Cullen, president DRUG TYPE: Biopharmaceuticals Boehringer Ingelheim Biopharmaceuticals GmbH Ingelheim, Germany Manufacturing locations: Biberach, Germany; Fremont, CA, U.S.A.; Shanghai, China; and Vienna, Austria www.bioxcellence.com +49 6132 770 Contact: Pauline Bronzel paulineeva.bronzel@boehringer-ingelheim.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical and clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development, drug substance production; Formulated Drug Production — dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, cartridges, injectables, liquids, lyophilized products, parenterals (large volume), parenterals (small volume), peptides, proteins, sterile, sustained release, syringes (prefilled), and vaccines. "We are a leading biopharma contract manufacturer with 35 years of experience and an outstanding track record of 22 products brought to market. As an independent, family-owned company, we see the contract manufacturing business as an important pillar of our biopharma activities, which is underlined with our new marketing brand Boehringer Ingelheim BioXcellence™. We offer tailor-made contract development and manufacturing services to the biopharmaceutical industry, providing the entire production technology chain, from DNA to fill and finish, under one roof at its facilities in Germany, Austria, U.S.A., and soon in China. With our global key account management team we are close to our customers and continue to put our customers first — We make outsourcing easy." — Folker Ruchatz, senior vice president contract manufacturing business biopharmaceutical Cangene bioPharma, Inc. Baltimore, MD Manufacturing locations: Baltimore, MD www.cangenebiopharma.com (410) 843-5000 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Contact: Pat DePalma depalmap@cangenebiopharma.com DRUG LIFE CYCLE STAGES: Research & Development — clinical (phase 1, phase 2, and phase 3); Formulated Drug Production — dosage form production and packaging SERVICES OFFERED: Aseptic fill/finish, generics, injectables, liquids, lyophilized products, ophthalmics, parenterals (small volume), peptides, sterile, and syringes (prefilled). "Our Cangene team has earned these rankings. They are a reflection of us, the people. We are truly service-oriented and focused on making a difference with our customers and with our customers' customers, all the way to the people who need the drug products we manufacture. Although bound by industry regulations, we use creativity to improve as we continue to learn — this is the way we do business. Our customer-focused spirit and attention to quality are evident and recognized globally." — Vicki Wolff-Long, Ph.D., general manager The CMO Leadership Awards 2013 35